Printer Friendly

Articles from MondayMorning (April 12, 2010)

1-26 out of 26 article(s)
Title Author Type Words
A federal judge reserved ruling on a guilty plea by Boston Scientific Corp (Natick MA) Guidant unit to charges it hid problems with its implantable heart defibrillators, citing objections raised by plaintiffs suing the company. Brief article 284
Aetna Inc. Brief article 260
Alimera Sciences Inc. Brief article 301
Amylin Pharmaceuticals Inc (San Diego CA) and Eli Lilly & Co's (Indianapolis IN) long-acting Byetta may be tied to increased cancer risk, a top US regulator said, raising concerns that the experimental diabetes drug may need strict warnings. Brief article 249
Boston Scientific weighing sale of two units. Boston Scientific Corp. Brief article 299
Complex back surgeries in older adults soared 15-fold from 2002 to 2007, driving up medical costs and the risk that patients may develop life-threatening complications, a study found. Brief article 263
FDA roundup: Aurobindo Pharma Ltd. 762
FDA to focus on radiation-therapy devices. 366
Federal court affirms ruling for AstraZeneca. Brief article 294
HCA said to prepare $3 billion IPO four years after leveraged buyout. HCA Inc. 472
LCA-Vision Inc. Brief article 119
Lithium may not have harmful neuropsychological effects on patients with bipolar illness, new research suggests. 308
Markets: the stock market closed at a new 18-month high Friday, with the Dow Jones industrial average briefly touching 11,000 before retreating slightly. Statistical data 344
Medical stock spotlight: Radient Pharmaceuticals Corp. 432
Merck & Co. Brief article 160
Pfizer agrees to first Neurontin lawsuit settlement. Pfizer Inc. Brief article 310
Pfizer sees bonanza for new Alzheimer's, cancer drugs. Pfizer Inc. Brief article 263
Sanofi-Aventis SA's (Paris, France) heart-rhythm drug Multaq, which has suffered from slow sales in the United States and Europe, is only modestly effective and has no clear safety benefits, researchers reported. 318
Sanofi-Aventis SA. Brief article 185
Sebelius begins push for high-risk pools. Brief article 243
Tracking Washington. Brief article 211
Upgrading traditional 2 chamber cardiac pacemakers to modern 3 chamber pacemakers--cardiac resynchronization therapy (CRT) devices--improves left ventricular ejection fraction (LVEF), researchers reported online March 16th in the European Heart Journal. Brief article 226
Verizon Communications Inc (New York), the second-largest US phone company, became the latest company to record a cost-related charge due to the US healthcare overhaul, saying it will incur a $970 million expense. 272
Weekly key rates. Brief article 110
Weekly stock performance. Statistical table 454
Women's risk of developing breast cancer may increase as much as 20-fold if they were treated with chest radiation for malignancies as children or young adults, according to an analysis of studies. Brief article 279

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters